Journal Article Research Support, Non-U.S. Gov't Ppublish 17 citations
PubMed: 35080734 DOI: 10.1007/s12975-021-00983-5
Test-retest reliability of arterial spin labelling for cerebral blood flow in older adults with small vessel disease.
Transl Stroke Res 13(4):583-594
Authors: Lauren R Binnie, Mathilde M H Pauls, Philip Benjamin, Mohani-Preet K Dhillon, Shai Betteridge, Brian Clarke, Rita Ghatala, Fearghal A H Hainsworth, Franklyn A Howe, Usman Khan, Christina Kruuse, Jeremy B Madigan, Barry Moynihan, Bhavini Patel, Anthony C Pereira, Egill Rostrup, Anan B Y Shtaya, Catherine A Spilling, Sarah Trippier, Rebecca Williams, Jeremy D Isaacs, Thomas R Barrick, Atticus H Hainsworth
Affiliations
- Molecular & Clinical Sciences Research Institute, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK.
- Department of Neurology, St George's University Hospitals NHS Foundation Trust London, London, UK.
- Department of Neuroradiology, St George's University Hospitals NHS Foundation Trust London, London, UK.
- Department of Neuropsychology, St George's University Hospitals NHS Foundation Trust London, London, UK.
- Department of Neurology and Neurovascular Research Unit, Herlev Gentofte Hospital, Herlev, Denmark.
- Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland.
- Mental Health Centre, University of Copenhagen, Glostrup, Denmark.
- South London Stroke Research Network, St George's Hospital, London, UK.
- Molecular & Clinical Sciences Research Institute, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK.
- Department of Neurology, St George's University Hospitals NHS Foundation Trust London, London, UK.
Abstract
Cerebral small vessel disease (SVD) is common in older people and is associated with lacunar stroke, white matter hyperintensities (WMH) and vascular cognitive impairment. Cerebral blood flow (CBF) is reduced in SVD, particularly within white matter.Here we quantified test-retest reliability in CBF measurements using pseudo-continuous arterial spin labelling (pCASL) in older adults with clinical and radiological evidence of SVD (N=54, mean (SD): 66.9 (8.7) years, 15 females/39 males). We generated whole-brain CBF maps on two visits at least 7 days apart (mean (SD): 20 (19), range 7-117 days).Test-retest reliability for CBF was high in all tissue types, with intra-class correlation coefficient [95%CI]: 0.758 [0.616, 0.852] for whole brain, 0.842 [0.743, 0.905] for total grey matter, 0.771 [0.636, 0.861] for deep grey matter (caudate-putamen and thalamus), 0.872 [0.790, 0.923] for normal-appearing white matter (NAWM) and 0.780 [0.650, 0.866] for WMH (all p<0.001). ANCOVA models indicated significant decline in CBF in total grey matter, deep grey matter and NAWM with increasing age and diastolic blood pressure (all p<0.001). CBF was lower in males relative to females (p=0.013 for total grey matter, p=0.004 for NAWM).We conclude that pCASL has high test-retest reliability as a quantitative measure of CBF in older adults with SVD. These findings support the use of pCASL in routine clinical imaging and as a clinical trial endpoint.All data come from the PASTIS trial, prospectively registered at: https://eudract.ema.europa.eu (2015-001235-20, registered 13/05/2015), http://www.clinicaltrials.gov (NCT02450253, registered 21/05/2015).
MeSH
White Matter, Gray Matter, Blood, Stroke, Brain, Blood Circulation
Cited by
- Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Netw Open, 2023
- Linking peripheral atherosclerosis to blood-brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment. Geroscience, 2024
- Recent advances in arterial spin labeling perfusion MRI in patients with vascular cognitive impairment. J Cereb Blood Flow Metab, 2023
- In vivo detection of oxidative stress and iron deposition by proton exchange rate ( ) MRI and quantitative susceptibility mapping for differentiating multiple sclerosis from cerebral small vessel diseases. Quant Imaging Med Surg, 2025
- Test-retest reliability of 3D velocity-selective arterial spin labeling for detecting normal variations of cerebral blood flow. Neuroimage, 2023
- Changes in brain connectivity and neurovascular dynamics during dexmedetomidine-induced loss of consciousness. bioRxiv, 2024
- A multicenter, single-arm, phase II clinical trial of adrenomedullin in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Cereb Circ Cogn Behav, 2024
- Perfusion heterogeneity of cerebral small vessel disease revealed via arterial spin labeling MRI and machine learning. Neuroimage Clin, 2022